DARA BioSciences, Inc. (DARA)

[LaJollaCA]

They who? You? Stop spreading lies. Oct. - Nov.

From Jason N. August 15th:

However, the biggest catalyst on the horizon is the pending ODD decision by the U.S. FDA, expected in October or November 2013. A positive decision on this front has the potential to double the shares, and lead to a partnership for KRN5500 from a larger pharmaceutical company that could bring in significant upfront cash. With this cash, Dara can funnel money back to increasing the market and promotion around Soltamox and Gelclair.

http://seekingalpha.com/article/1638362-patience-required-for-dara-bio-investment